Mode
Text Size
Log in / Sign up
N/A Completed N=102 Prevention

Supported Employment COVID-19 Rapid Testing for PWID

Health Behavior
Source: ClinicalTrials.gov NCT05984966 ↗
Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcomePrimary: Participant Peer Well-Being (Flourishing Scale) — 5.00; 4.89 units on a scale — p=.620

Summary

This community-engaged project aims to improve the accessibility of rapid tests through a supported employment program for people who inject drugs (PWID). The overall goal is to develop a transformative community-driven intervention in partnership with a community partner to promote widespread access to rapid testing among PWID.

Outcome Measures

OutcomeResultp-value
PRIMARY
Participant Peer Well-Being (Flourishing Scale)
5.00; 4.89 .620
SECONDARY
Health Communication Self-Efficacy
3.66; 3.90 .071
SECONDARY
Peer Support Self-Efficacy
4.10; 4.08 .951
SECONDARY
COVID-19 Knowledge
2.06; 2.41 .094
SECONDARY
HIV Knowledge
1.59; 1.90 .100
SECONDARY
Hepatitis C Knowledge
0.97; 1.20 .100
SECONDARY
Syphilis Knowledge
1.92; 2.29 .045 sig
SECONDARY
Naloxone Knowledge
2.84; 2.96 .590
SECONDARY
Harm Reduction Risk Behaviors - Number of Times a Person Injected Drugs
1.26; 0.86 .096
SECONDARY
Harm Reduction Risk Behaviors - Number of Times a Person Used Needles
4.46; 4.78 .795
SECONDARY
Harm Reduction Risk Behaviors - Number of Times Person Engaged in Risky Intercourse Behaviors
8.18; 8.31 .913

Eligibility Criteria

Inclusion Criteria

  • Age 18 and older
  • Able to speak and understand English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05984966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search